Concepedia

Guozhi Gao

GG

Statistics

Publications

17

Citations

1.9K

H-Index

16

Active since

2005

Affiliations

Amgen (United States)(Current)

Sanofi (United States)

Mayo Clinic in Arizona

University of California San Diego

The University of Texas MD Anderson Cancer Center

Guozhi Gao is an author at Amgen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

2005–2018

17

Publications

17

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

Karim Fizazi, Allan Lipton, Xavier Mariette et al. · Journal of Clinical Oncology · 2009 · 534 citations

, , +17

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

Animesh Pardanani, Claire Harrison, Jörge E. Cortes et al. · JAMA Oncology · 2015 · 472 citations

, , +14

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Clinical Cancer Research · 2008 · 161 citations · Full text

, , +17

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Jean‐Jacques Body, Allan Lipton, Julie R. Gralow et al. · Journal of Bone and Mineral Research · 2009 · 120 citations

, , +17

Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial

Karim Fizazi, Linda D. Bosserman, Guozhi Gao et al. · The Journal of Urology · 2012 · 111 citations

, , +17

1–5 of 17